Parexel's COVID-19 expert content

  • The Parexel Podcast | Episode 15: Pandemic preparedness: Investing in the future of infectious disease vaccine development

    The Parexel Podcast | Episode 15: Pandemic preparedness: Investing in the future of infectious disease vaccine development

    Learn More
  • Drug Development for Rare Disease and Oncology During the COVID-19 Pandemic

    Drug Development for Rare Disease and Oncology During the COVID-19 Pandemic

    Learn More
  • How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen

    How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen

    About the Authors Aaron Dy, Ph.D. is a Senior Analyst in the Health Advances...

    Learn More
  • Biopharma R&D in the Post-COVID World

    Biopharma R&D in the Post-COVID World

    About the Authors Steven Chang, Ph.D. is a Senior Analyst in the Health...

    Learn More
  • eBook: Biopharma in the COVID-19 World

    eBook: Biopharma in the COVID-19 World

    Learn More
  • The Special Approval Pathway (SAP) for COVID-19 related products in China

    The Special Approval Pathway (SAP) for COVID-19 related products in China

    The regulatory pathway for COVID-19 drugs in China is governed by the Special Approval Program (SAP) which was introduced by National Medical Product Administration (NMPA) in 2005.  SAP is...

    Learn More
  • NMPA Guidance on the Management of Clinical Trials during the COVID-19 from July 2020

    NMPA Guidance on the Management of Clinical Trials during the COVID-19 from July 2020

    Conducting clinical trials during the COVID-19 pandemic has produced many challenges globally. The initiation, conduct, implementation and completion of a trial during this time requires special...

    Learn More
  • Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

    Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

    Key Takeaways The COVID-19 pandemic has drawn attention to international efforts to promote...

    Learn More
  • The New Pragmatism: Clinical Trials, Investment and Regulations Post-COVID-19

    The New Pragmatism: Clinical Trials, Investment and Regulations Post-COVID-19

    Once the COVID-19 pandemic passes or is contained, the world will look and work very differently. The biopharmaceutical industry is no exception. In this podcast, Peyton Howell, Parexel’s Chief...

    Learn More
  • Demystifying SARS-CoV-2 Testing for COVID-19 (Third Edition – Part 1: Updates and Trends)

    Demystifying SARS-CoV-2 Testing for COVID-19 (Third Edition – Part 1: Updates and Trends)

    Click here to download the full presentation. SummaryAs the world continues to battle...

    Learn More
  • An opportunity in a time of crisis: COVID-19 and the new pragmatism

    An opportunity in a time of crisis: COVID-19 and the new pragmatism

    View Now
  • FDA Expectations for Responding to Employees in Pharmaceutical Manufacturing Infected with COVID-19

    FDA Expectations for Responding to Employees in Pharmaceutical Manufacturing Infected with COVID-19

    Global manufacturers and regulators are facing new challenges during the SARS-CoV-2 pandemic to maintain supply chains, and avoid shortages, of drugs, biologics and medical devices.  Numerous...

    Learn More
  • eBook: Digital Health and the Global Pandemic

    eBook: Digital Health and the Global Pandemic

    Learn More
  • EMA Guidance: Management of Clinical Trials - What it means for Patients?

    EMA Guidance: Management of Clinical Trials - What it means for Patients?

    A lay summary for patients participating in clinical trials

    View Now
  • Using risk assessment decision tree models to maintain safety and data validity in clinical trials during COVID-19

    Using risk assessment decision tree models to maintain safety and data validity in clinical trials during COVID-19

    During the COVID-19 pandemic, challenges to the conduct of clinical trials may arise, e.g. due to travel restrictions or quarantines, interruptions to supply chains, or when site personnel or...

    Learn More
  • Putting the Pandemic in Plain Language

    Putting the Pandemic in Plain Language

    The COVID-19 pandemic has brought many negative feelings to the forefront of our everyday lives, including anxiety, fear and social division, but what if we explored the new positive relationships...

    Learn More
  • SARS-CoV-2 Landscape of Repurposed Drug Trials and Key Lessons for the Future

    SARS-CoV-2 Landscape of Repurposed Drug Trials and Key Lessons for the Future

    About the Authors Saakshi Chadha, PhD is a Senior Analyst in the Health...

    Learn More
  • COVID-19: Digestive symptoms of the novel virus and implications for clinical trials

    COVID-19: Digestive symptoms of the novel virus and implications for clinical trials

    As the entire healthcare ecosystem grapples with the COVID-19 virus, more evidence surfaces every day of manifestations beyond fever, respiratory symptoms and fatigue. In fact, a recent...

    Learn More
  • Navigating new steps in how FDA is managing COVID-19 Products

    Navigating new steps in how FDA is managing COVID-19 Products

    Learn More
  • Biosimilars in the time of COVID-19 and beyond

    Biosimilars in the time of COVID-19 and beyond

    Introduction The recent COVID-19 pandemic has triggered a race for pharmaceutical companies to repurpose their commercialized drugs approved for other clinical indications to treat patients...

    Learn More
  • loading
    Loading More...